Physician profile
Emad Milad
NPI 1457359853
$2,796.91
in general payments reported to CMS, 2019-2025
9 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $247 · 2021: $682 · 2022: $79.75 · 2023: $125 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $665.27 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $560.91 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $367.65 | 2019-2020 | |
| Axsome Therapeutics, INC. | $366.36 | 2023-2025 | Auvelity |
| Allergan, INC. | $243.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $237.26 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.72 | 2021 | |
| Sunovion Pharmaceuticals INC. | $123.42 | 2019 | |
| Biogen, INC. | $106.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Milad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.